GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PBX1 | hg19_v2_chr1_+_164529004_164529060 | -0.13 | 5.9e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_+_140135665 Show fit | 23.24 |
ENST00000340384.4
|
tubulin, beta 4B class IVb |
|
chr4_+_83956237 Show fit | 14.04 |
ENST00000264389.2
|
COP9 signalosome subunit 4 |
|
chr4_+_83956312 Show fit | 14.00 |
ENST00000509317.1
ENST00000503682.1 ENST00000511653.1 |
COP9 signalosome subunit 4 |
|
chr18_+_29171689 Show fit | 12.57 |
ENST00000237014.3
|
transthyretin |
|
chr8_+_98788003 Show fit | 11.57 |
ENST00000521545.2
|
lysosomal protein transmembrane 4 beta |
|
chr10_-_101190202 Show fit | 8.94 |
ENST00000543866.1
ENST00000370508.5 |
glutamic-oxaloacetic transaminase 1, soluble |
|
chr3_+_159557637 Show fit | 8.26 |
ENST00000445224.2
|
schwannomin interacting protein 1 |
|
chr4_+_69962185 Show fit | 8.00 |
ENST00000305231.7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
|
chr16_+_15596123 Show fit | 7.99 |
ENST00000452191.2
|
chromosome 16 open reading frame 45 |
|
chr4_+_69962212 Show fit | 7.66 |
ENST00000508661.1
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 28.0 | GO:0000338 | protein deneddylation(GO:0000338) |
0.3 | 22.1 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.8 | 17.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.5 | 13.8 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
1.3 | 13.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.0 | 12.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
4.1 | 12.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.3 | 12.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.8 | 11.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.0 | 10.3 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 31.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.5 | 28.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 14.9 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 14.4 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.9 | 13.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 13.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.5 | 12.4 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 12.1 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 10.4 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
2.6 | 10.3 | GO:0070985 | TFIIK complex(GO:0070985) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 28.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.7 | 24.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.7 | 23.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.6 | 12.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
1.3 | 12.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.5 | 12.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 12.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
2.1 | 12.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.8 | 12.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 10.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 14.4 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 14.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 12.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 10.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 10.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 7.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 6.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 6.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 5.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 4.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 23.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.9 | 23.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.7 | 17.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.1 | 13.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.7 | 12.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 11.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.4 | 10.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.5 | 7.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 7.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 6.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |